ArticleFish physiology and biochemistry2026
Sodium butyrate improved intestinal function in normal and glyphosate-challenged Nile tilapia (Oreochromis niloticus L.).
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effects of dietary sodium butyrate supplementation on Nile tilapia, with emphasis on growth performance, biochemical alterations, histological characteristics, and gene expression patterns under both normal conditions and glyphosate exposure. A total of 90 Nile tilapia with an initial mean body weight of 7.93 ± 0.026 g were randomly allocated into two experimental groups, with each group comprising three replicate units. The control group was fed a basal diet, while the second group received 1.5 g/kg of sodium butyrate mixed into their food for 8 weeks. Afterward, each group was further divided into two: one without any challenge and the other exposed to 0.6 mg/L GLY. The findings indicated that fish fed with SB exhibited a significant improvement (p < 0.05) in final body weight (FBW), weight gain percentage (WG %), specific growth rate (SGR), protein efficiency ratio (PER), and survival rate, along with a reduction in feed conversion ratio (FCR) compared to the control group. Additionally, there was an enhancement in hepatic antioxidant capacity, along with a downregulation of hepatic ilgf1bp and myostatin. Fish subjected to GLY displayed the highest activities of ALT and AST, elevated levels of BUN and creatinine, and a decrease in lysozyme activity. Sodium butyrate supplementation mitigated glyphosate-induced hepatic and renal impairment and regulated the mRNA expression of intestinal tight junction-associated and apoptosis-related genes. These findings suggest that dietary sodium butyrate may be used as a promising alternative feed additive in sustainable Nile tilapia aquaculture. Its inclusion could help protect fish against glyphosate-associated stress, improve growth performance, enhance antioxidant and immune-related biochemical responses, and provide anti-inflammatory and anti-apoptotic benefits under both basal conditions and following glyphosate exposure.
Indexed as
Identifiers
42295498What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.